1. Achenbach, T. M. (1991). Integrative guide to the 1991 CBCl/4-18, YSR, and TRF profiles. Burlington: University of Vermont, Department of Psychology.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders fourth edition test revision (DSM-IV-TR). Washington. D.C.
3. Amiet, C., Gourfinkel-An, I., Bouzamondo, A., Tordjman, S., Baulac, M., Lechat, P., et al. (2008). Epilepsy in autism is associated with intellectual disability and gender: evidence form a meta-analysis. Biological Psychiatry, 64, 577–582. doi: 10.1016/j.bio.psych.2008.04.030 .
4. Anagnostou, E., Esposito, K., Soorya, L., Chaplin, W., Wasserman, S., & Hollander, E. (2006). Sivalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder. Journal of Clinical Psychopharmacology, 26(4), 444–446. doi: 10.1097/01.jcp. 0000227703.72117.bc .
5. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders Test Revision (DSM-IV-TR). Washington. D.C